Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit

Area of Science:

• Neuroscience
• Neurodegenerative Diseases
• Molecular Biology

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder affecting spinal motoneurons.
• While mutated superoxide dismutase 1 (SOD1) is linked to familial ALS, its role in sporadic ALS is unclear.
• Existing research suggests factors beyond superoxide metabolism contribute to sporadic ALS pathogenesis.

Purpose of the Study:

• To investigate the role of increased calcium permeability in AMPA receptors in spinal motoneuron degeneration.
• To determine if altered AMPA receptor function contributes to the pathogenesis of sporadic ALS.
• To examine the interaction between altered AMPA receptors and mutated SOD1 in disease progression.

Main Methods:

• Transgenic mice expressing GluR-B(N)-containing AMPA receptors with increased Ca(2+) permeability were utilized.
• Assessment of neuronal degeneration, motor function decline, and survival rates in these mice.
• Co-expression of mutated human SOD1 in transgenic mice to evaluate combined effects on disease progression.

Main Results:

• Transgenic expression of Ca(2+)-permeable AMPA receptors induced late-onset spinal motoneuron degeneration and motor decline.
• Neuronal death progressed throughout life, mimicking slow neurodegenerative disorders.
• Co-expression of mutated SOD1 significantly accelerated disease progression, worsened motor deficits, and reduced survival.

Conclusions:

• Persistently elevated Ca(2+) influx through AMPA channels is linked to progressive motor decline and spinal motoneuron degeneration.
• Functionally altered AMPA receptors may be causally involved in the pathogenesis of sporadic ALS.
• These findings highlight potential therapeutic targets for ALS unrelated to superoxide metabolism.